BioNTech Archives - Maritime Shipping News

“Long Wait Comes To An End”: Cancer Vaccines To Become A Reality Soon!

19 October 2022

The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine, reports ABC News.

Cancer vaccine development

“We feel that a cure for cancer or to changing cancer patients’ lives is in our grasp,” professor Ozlem Tureci told BBC News in an interview over the weekend. Her husband, professor Ugur Sahin, with whom she cofounded the German pharmaceutical company BioNTech, said he thought cancer vaccines could be widely available...

https://mfame.guru/long-wait-comes-to-an-end-cancer-vaccines-to-become-a-reality-soon/

Moderna Files Suit Against Pfizer & BioNTech

30 August 2022

Moderna is suing Pfizer and BioNTech for allegedly infringing on patents the company filed from 2010 to 2016, reports Pharmaceutical Technology.

Patent infringement lawsuits

Moderna announced on Aug. 26, 2022 that it was filing patent infringement lawsuits against Pfizer and BioNTech over a dispute concerning the company’s Comirnaty vaccine. Moderna alleges that Pfizer and BioNTech infringed on patents Moderna filed between 2010 and 2016 concerning the company’s mRNA technology, which they allege...

https://mfame.guru/moderna-files-suit-against-pfizer-biontech/

Pharma firms working together to make each other’s vaccines

16 March 2021

Visual inspection of vaccine vials at a Merck production facility. (Photo: Copyright © 2009-2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co. Inc., Kenilworth, New Jersey, U.S.A. All rights reserved.)

This is an excerpt from the March 16, 2021 edition of Medically Necessary, a health care supply chain newsletter. Subscribe here.

Good afternoon. Medically Necessary is a newsletter by Matt Blois about the health care supply chain — how we get drugs, devices and medical supplies to health care providers and patients.

Pharma firms working together to make each other’s vaccines

https://s29755.pcdn.co/news/pharma-firms-working-together-to-make-each-others-vaccines

Commentary: Washington must quickly build confidence in vaccine supply chain

18 January 2021

The jubilation Americans felt about the speed with which Pfizer and BioNTech, Moderna, AstraZeneca and Oxford University, and other groups developed their respective versions of a vaccine for COVID-19 has met the cold, hard reality of just how complex supply chains can be.

On one hand we read about how Israel has vaccinated 20% of its population within three weeks. On the other hand we are confronted with record deaths from COVID-19 in the United States in the midst of a very slow start to the...

https://s29755.pcdn.co/news/commentary-washington-must-quickly-build-confidence-in-vaccine-supply-chain

Commentary: Adding COVID-19 vaccines to the holiday rush

23 December 2020

The views expressed here are solely those of the author and do not necessarily represent the views of FreightWaves or its affiliates.

The rapid spread of COVID-19 early this year was certainly facilitated by the speed and efficiency of modern transportation. It is with a touch of irony, but with a lot more hope, that modern transportation can deliver the new vaccines rapidly and widely enough to help end the pandemic sometime next year.

The race by pharmaceutical companies to develop and...

https://www.freightwaves.com/news/commentary-adding-covid-19-vaccines-to-the-holiday-rush

COVID-19 Vaccine Would be Effective Against Variant of Coronavirus?

23 December 2020

According to an article published in Reuters BioNTech Chief Executive Ugur Sahin said on Monday he was confident a COVID-19 vaccine co-developed by his company would be effective against a variant of the coronavirus that has emerged in Britain.

Ugur Sahin Interview with Bild TV

He said on Bild TV that “the German company would investigate the mutation in the coming days but that he viewed the matter with with a degree of soberness”.

New coronavirus Variant

Countries across the globe shut their...

https://mfame.guru/covid-19-vaccine-would-be-effective-against-variant-of-coronavirus/

Vaccine distribution, peak-season climax spawn parcel delivery storm

15 December 2020

A tumultuous year for the parcel-delivery business has been taken to another level as parcel shippers find themselves competing with the most precious of cargoes for peak holiday season air and surface capacity.

To the amazement of many, the first of what are expected to be several vaccines to crush the novel coronavirus has been approved by federal regulators and shipped out before the end of 2020. The timing of these extraordinary developments has an unintended consequence in that it...

https://www.freightwaves.com/news/vaccine-distribution-peak-season-climax-spawn-parcel-delivery-storm

Pfizer Vaccine Data Breach Shows the Extent of Vaccine Cyber Threat

10 December 2020

The European Medicines Agency (EMA) says it has been hit by a cyber-attack and documents relating to a Covid-19 vaccine have been accessed, reports BBC.

What happened?

BioNTech, which makes one of the vaccines in partnership with Pfizer, said its regulatory submission was accessed during the attack.

The EMA is working on approval of two Covid-19 vaccines, which it expects to conclude within weeks.

No Impact on Vaccine Approval?

The cyber-attack was not expected to impact that timeline, BioNTech...

https://mfame.guru/pfizer-vaccine-data-breach-shows-the-extent-of-vaccine-cyber-threat/

Pfizer COVID Vaccine Ready To Roll Out After Emergency Authorization

2 December 2020

The Pfizer-BioNTech COVID-19 vaccine will be made available across the UK from next week.
The U.K. government says frontline health care workers and nursing home residents will be first in line to get vaccinated, followed by older adults.
This 95 percent effectiveness rate brings the experimental candidate on par with the likes of shingles and measles vaccines.

Britain became the first country in the world to approve the COVID-19 vaccine developed by U.S. drugmaker Pfizer and its German...

https://mfame.guru/pfizer-covid-vaccine-ready-to-roll-out-after-emergency-authorization/

Will Trials Alter the 90% Efficacy of Pfizer Vaccine?

30 November 2020

Pfizer and BioNTech said they had identified 94 cases of COVID-19 among 43,538 trial participants.
The split of cases between the groups suggested that the vaccine was more than 90% effective at preventing disease.
The trial will continue until a total of 164 COVID-19 cases are detected, so initial estimates of the vaccine’s effectiveness could change.
Pfizer and BioNTech reported that 42% of participants had racially and ethnically diverse backgrounds.

Scientists have greeted with cautious...

https://mfame.guru/will-trials-alter-the-90-efficacy-of-pfizer-vaccine/

+ More